$KRMD News

KORU Medical Systems Presents Data Titled 'Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration' At Oncology Nursing Society Congress

KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript

KORU Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation

KORU Medical Systems (NASDAQ:KRMD) Soars 16% After Q1 Earnings Beat

KORU Medical Systems Affirms FY2026 Sales Guidance of $47.500M-$50.000M vs $48.516M Est

KORU Medical Systems Q1 Sales $11.765M Beat $11.284M Estimate

B. Riley Securities Maintains Buy on KORU Medical Systems, Raises Price Target to $8

KORU Medical Systems' Freedom60 Infusion Pump Achieves Certification Under European Union Medical Devices Regulation

KORU Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation

KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript

KORU Medical Systems Appoints Adam Kalbermatten President, CEO, Succeeding Linda Tharby

KORU Medical Systems Sees FY2026 Sales $47.500M-$50.000M vs $48.476M Est

KORU Medical Systems Q4 Adj. EPS $0.01 Beats $(0.02) Estimate, Sales $10.895M Beat $10.821M Estimate

KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround

An Intrinsic Calculation For KORU Medical Systems, Inc. (NASDAQ:KRMD) Suggests It's 48% Undervalued

KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock?

KORU Medical receives FDA clearance for FreedomEDGE infusion system

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

KORU Medical Systems shares are trading higher after the company announced FDA clearance for use of the KORU Medical FreedomEDGE infusion system to deliver RYSTIGGO.